Surface plasmon resonance and free oscillation rheometry in combination: a useful approach for studies on haemostasis and interactions between whole blood and artificial surfaces.
In haemostatic and biomaterial research biological processes at surfaces and in the bulk phase of the surface-contacting medium are important. The present work demonstrates the usefulness of the combination of surface plasmon resonance (SPR), sensitive to changes in refractive index at surfaces, and free oscillation rheometry (FOR), sensitive to rheological properties of the bulk, for simultaneous real-time measurements on coagulation and fibrinolysis of blood plasma and coagulation of whole blood. SFLLRN stimulated coagulation of native whole blood presented a higher SPR signal with different appearance than plasma coagulation, while the FOR signals corresponding to plasma and whole blood coagulation were similar. This indicated that the SPR technique was more sensitive to cell-surface interactions than to fibrin formation in whole blood during coagulation, while the FOR technique were equally sensitive to coagulation in whole blood and plasma. Spontaneous coagulation of native whole blood in contact with methyl- and hydroxyl-terminated self-assembled monolayers (SAM) on gold and gold surfaces regenerated after coagulation were also studied. The regenerated gold surfaces displayed the shortest coagulation times, although the contact-activation of blood coagulation for these surfaces was low. The methylated and hydroxylated surfaces were comparable in terms of coagulation activation, while the hydroxylated surfaces presented FOR signals that indicated detaching of the coagulum from the surface. The combination of SPR and FOR is well suited for studies of cell- and protein-surface interactions and simultaneous bulk processes. Possible applications are investigations of blood cell defects in patients and monitoring of native whole blood interactions with artificial surfaces.
Hansson
Kenny M
KM
Department of Biomedicine and Surgery, Division of Clinical Chemistry, Linköping University Hospital, SE-581 85, Linköping, Sweden. kenny.m.hansson@astrazeneca.com
Tengvall
Pentti
P
Lundström
Ingemar
I
Rånby
Mats
M
Lindahl
Tomas L
TL
D001672:Biocompatible Materials; D001769:Blood; D001777:Blood Coagulation; D002448:Cell Adhesion; D005342:Fibrinolysis; D018056:Hemorheology / Q000295:instrumentation / Q000379:methods*; D006487:Hemostasis; D006801:Humans; D008422:Materials Testing / Q000295:instrumentation / Q000379:methods; D009991:Oscillometry / Q000295:instrumentation / Q000379:methods*; D010949:Plasma; D012680:Sensitivity and Specificity; D020349:Surface Plasmon Resonance / Q000295:instrumentation / Q000379:methods*; D013499:Surface Properties
D001672:Biocompatible Materials